Legal Opinion
Pharmaceutical Research and Manufacturers of America v. Walsh, Acting Commissioner, Maine Department of Human Services
Supreme Court of the United States
Decided May 19, 2003No. 01-188PublishedCited by 279 opinions
1Judgment of the CourtJustice Stevens
In response to increasing Medicaid expenditures for prescription drugs,1 Congress enacted a cost-saving measure in 1990 that requires drug companies to pay rebates to States on their Medicaid purchases. Over the last several years, state legislatures have enacted supplemental rebate programs to achieve additional cost savings on Medicaid purchases as well as for purchases made by other needy citizens. The “Maine Rx” program, enacted in 2000, is primarily intended to provide discounted prescription drugs to Maine’s uninsured citizens but its coverage is open to all residents of the State.…
2Cases cited16 opinions
- Mazurek v. ArmstrongSupreme Court of the United States · 1997
- Hillsborough County v. Automated Medical Laboratories, Inc.Supreme Court of the United States · 1985
- Doran v. Salem Inn, Inc.Supreme Court of the United States · 1975
- Alexander v. ChoateSupreme Court of the United States · 1985
- King v. SmithSupreme Court of the United States · 1968
11 more not listed; retrieve them via the Exa API.
3Cited by279 opinions
- Armstrong v. Exceptional Child Center, Inc.Supreme Court of the United States · 2015
- Arar v. AshcroftCourt of Appeals for the Second Circuit · 2009
- Warsoldier v. WoodfordCourt of Appeals for the Ninth Circuit · 2005
- Commonwealth v. Abdul-SalaamSupreme Court of Pennsylvania · 2002
- Warsoldier v. WoodfordCourt of Appeals for the Ninth Circuit · 2005
274 more not listed; retrieve them via the Exa API.